Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,889,803
+$23,323,536 QoQ
Shares Held
402,192
+252.6% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#62
of 504 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Derivatives in IONS
reported options exposure · as of Jun 30, 2026CallValue
$4,709,826
CallShares
59,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA HOLDINGS INC holds $206,438,773 across 46 Biotechnology names. IONS ranks #1 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
This page
|
402,192 | $31,889,803 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
327,475 | $24,390,338 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
61,938 | $19,577,982 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
978,602 | $16,606,875 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
417,932 | $15,216,904 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,198 | $14,503,522 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,320 | $8,929,092 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
1,637,081 | $7,857,988 |
All Filings in IONS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,889,803 | 402,192 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $4,709,826 | 59,400 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $8,566,267 | 114,080 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $4,460,346 | 59,400 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $7,586,649 | 95,900 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $2,135,970 | 27,000 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $67,149,754 | 848,815 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $47,978,896 | 733,398 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,185,300 | 30,000 | Put | Defined | 2025-08-18 | |
| 2025-06-30 | $1,185,300 | 30,000 | Call | Defined | 2025-08-18 | |
| 2025-06-30 | $1,270,681 | 32,161 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $603,400 | 20,000 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $7,132,972 | 236,426 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,489,634 | 357,255 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,149,944 | 453,069 | Shares | Defined | 2025-01-13 | |
| 2024-06-30 | $23,886,620 | 501,188 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,410,783 | 470,837 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,748,071 | 489,189 | Shares | Defined | 2024-03-27 | |
| 2023-09-30 | $20,834,346 | 459,311 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $17,863,641 | 435,380 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,343,284 | 401,323 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,110,152 | 400,057 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $17,157,170 | 387,908 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $13,918,668 | 375,977 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,599,464 | 394,154 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $11,334,566 | 372,480 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,636,127 | 376,748 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,067,569 | 377,728 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $266,755 | 4,718 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||